Rite Aid, PBM division introduce Rx90

Print Friendly, PDF & Email
CAMP HILL, Pa. — Rite Aid Corp. and EnvisionRx, the pharmacy benefit management division of EnvisionRxOptions and a wholly owned subsidiary of Rite Aid, have debuted Rx90, a new program focused on improving medication adherence and health outcomes for consumers with chronic conditions.

Rx90, now available for EnvisionRx clients, gives consumers the option to fill their 90-day prescriptions at any of the nearly 4,600 Rite Aid pharmacy locations around the country. For the same price, consumers also have the option to have their medications delivered through EnvisionPharmacies’ mail ­service.

Other benefits of Rx90 include integrated care and clinical support from Rite Aid pharmacists and EnvisionRx; targeted, disease-specific communications; the largest 90-day retail maintenance medication network (over 12,000 total pharmacies); and reduced co-pays that provide most members with 15 to 30 days of free coverage.

Besides providing consumers with improved pricing, more convenient options on how to fill their 90-day maintenance medications and additional clinical support, the collaboration between Rite Aid and EnvisionRx helps to address rising health care costs.

According to a 2014 Towers Watson study on employer-provided health care, the consumer’s share of health care costs, including premiums and out-of-pocket expenditures, expanded from 34.4% in 2011 to 37% in 2014.

“Rx90 is a great example of how our pharmacies and PBMs can collaborate to achieve our shared goal of improving the patient experience and care, while reducing and managing health care costs,” said Rite Aid executive vice president of pharmacy Jocelyn Konrad.

Using client-specific data and its own research, EnvisionRx is also able to provide health plans and employers with recommendations on customizing their benefit design, communications and clinical strategies to meet their individual needs. Rx90 will help plan sponsors better control drug spend and reduce costly medical expenses associated with increased visits to physicians and emergency rooms, as well as extended ­hospitalizations.

“In today’s market, plan sponsors and their members need a PBM that truly provides more flexible, affordable options to control the costs of chronic care. Rx90 and our technology platform give plan sponsors another way to customize their prescription drug benefit plan and put actionable, cost-saving information in the hands of their members,” said EnvisionRxOptions chief executive officer Frank Sheehy.



Comments are closed.